PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis

PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis

Bibliographic Details
Main Authors:	Qingyu Zhang, Shun Lu, Dongsheng Zhou, Jun Dong, Fanxiao Liu
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-01-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304222000423

Similar Items

SOST/Sclerostin impairs the osteogenesis and angiogesis in glucocorticoid-associated osteonecrosis of femoral head
by: Junming Huang, et al.
Published: (2024-09-01)

Screening and identification of potential key biomarkers for glucocorticoid-induced osteonecrosis of the femoral head
by: Dan Chen, et al.
Published: (2023-01-01)

Activation of cannabinoid receptor 2 alleviates glucocorticoid-induced osteonecrosis of femoral head with osteogenesis and maintenance of blood supply
by: Houyi Sun, et al.
Published: (2021-10-01)

Role of coagulopathy in glucocorticoid-induced osteonecrosis of the femoral head
by: Qiankun Zhang, et al.
Published: (2018-06-01)

The Protective Effect of Luteolin in Glucocorticoid-Induced Osteonecrosis of the Femoral Head
by: Zijian Yan, et al.
Published: (2020-08-01)

Osteogenesis-Related Long Noncoding RNA GAS5 as a Novel Biomarker for Osteonecrosis of Femoral Head
by: Guanzhi Liu, et al.
Published: (2022-03-01)

Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway
by: Li Yugang, et al.
Published: (2021-10-01)

Icariin Protects against Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Rats
by: Zengfa Huang, et al.
Published: (2018-05-01)

Less sclerotic microarchitecture pattern with increased bone resorption in glucocorticoid-associated osteonecrosis of femoral head as compared to alcohol-associated osteonecrosis of femoral head
by: Yiwei Chen, et al.
Published: (2023-03-01)

The effect of endostatin on angiogenesis and osteogenesis of steroid-induced osteonecrosis of the femoral head in a rabbit model
by: Yan Zhao, et al.
Published: (2022-05-01)

Identification and Validation of Potential Ferroptosis-Related Genes in Glucocorticoid-Induced Osteonecrosis of the Femoral Head
by: Ning Chen, et al.
Published: (2023-02-01)

Femoral osteotomy for osteonecrosis of the femoral head
by: Goro Motomura
Published: (2023-12-01)

Research on Lipidomic Profiling and Biomarker Identification for Osteonecrosis of the Femoral Head
by: Yuzhu Yan, et al.
Published: (2024-12-01)

Osteoimmunology and osteonecrosis of the femoral head
by: Maoxiao Ma, et al.
Published: (2022-01-01)

Effects of Simvastatin on Cartilage Homeostasis in Steroid-Induced Osteonecrosis of Femoral Head by Inhibiting Glucocorticoid Receptor
by: Yaling Yu, et al.
Published: (2022-12-01)

Polarization Behavior of Bone Macrophage as Well as Associated Osteoimmunity in Glucocorticoid-Induced Osteonecrosis of the Femoral Head
by: Zhang Q, et al.
Published: (2023-02-01)

Altered lipidomic profiles in patients with and without osteonecrosis of the femoral head after 1‐month glucocorticoid treatment
by: Xin‐Yuan Wang, et al.
Published: (2021-02-01)

Exosomes derived from human CD34+ stem cells transfected with miR-26a prevent glucocorticoid-induced osteonecrosis of the femoral head by promoting angiogenesis and osteogenesis
by: Rongtai Zuo, et al.
Published: (2019-11-01)

Jintiange capsule ameliorates glucocorticoid-induced osteonecrosis of the femoral head in rats by regulating the activity and differentiation of BMSCs
by: Hui Xu, et al.
Published: (2024-09-01)

Cortistatin prevents glucocorticoid-associated osteonecrosis of the femoral head via the GHSR1a/Akt pathway
by: Yuan Gao, et al.
Published: (2024-01-01)

Metabolic Profiling Analysis of the Effect and Mechanism of Gushiling Capsule in Rabbits With Glucocorticoid-Induced Osteonecrosis of the Femoral Head
by: Runhong Mei, et al.
Published: (2022-05-01)

Pyroptosis -related potential diagnostic biomarkers in steroid-induced osteonecrosis of the femoral head
by: Jin-Lian Chai, et al.
Published: (2023-07-01)

Corticosteroid-induced Knee Osteonecrosis and Accompanying Femoral Head Osteonecrosis
by: Nuran Sabir, et al.
Published: (2019-07-01)

Hydrogel Use in Osteonecrosis of the Femoral Head
by: Zeynep Bal, et al.
Published: (2024-08-01)

Plasma SQSTM1/p62 act as a biomarker for steroid-induced osteonecrosis of the femoral head
by: Wenyuan Hou, et al.
Published: (2024-10-01)

Decreased angiogenic and increased apoptotic activities of bone microvascular endothelial cells in patients with glucocorticoid-induced osteonecrosis of the femoral head
by: Huachen Yu, et al.
Published: (2020-04-01)

Lithium chloride prevents glucocorticoid-induced osteonecrosis of femoral heads and strengthens mesenchymal stem cell activity in rats
by: Yue-Lei Zhang, et al.
Published: (2021-09-01)

Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid‐induced osteonecrosis of the femoral head
by: Ning Yang, et al.
Published: (2021-06-01)

Inhibition of insulin degrading enzyme suppresses osteoclast hyperactivity via enhancing Nrf2-dependent antioxidant response in glucocorticoid-induced osteonecrosis of the femoral head
by: Tao Yuan, et al.
Published: (2024-07-01)

Advances in experimental models of osteonecrosis of the femoral head
by: Zilin Li, et al.
Published: (2023-03-01)

Bisphosphonates for Post-COVID Osteonecrosis of the Femoral Head
by: Sanjay Agarwala, MCh(Ortho), et al.
Published: (2022-12-01)

Osteonecrosis of the Femoral Head with Collapsed Medial Lesion
by: Kazuyuki Karasuyama, et al.
Published: (2014-01-01)

Research Progress on Exosomes in Osteonecrosis of the Femoral Head
by: Xiuzhi Liu, et al.
Published: (2022-09-01)

Infographic: Osteoimmunology mechanism of osteonecrosis of the femoral head
by: Maoxiao Ma, et al.
Published: (2022-01-01)

Cell therapy for avascular osteonecrosis of femoral head
by: Tomoki Aoyama, et al.
Published: (2009-04-01)

Osteonecrosis of the Femoral Head with Collapsed Medial Lesion
by: Kazuyuki Karasuyama, et al.
Published: (2014-09-01)

Exosomes from miRNA-378-modified adipose-derived stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head by enhancing angiogenesis and osteogenesis via targeting miR-378 negatively regulated suppressor of fused (Sufu)
by: Kai Nan, et al.
Published: (2021-06-01)

Inhibition of sympathetic tone via hypothalamic descending pathway propagates glucocorticoid-induced endothelial impairment and osteonecrosis of the femoral head
by: Wenkai Shao, et al.
Published: (2024-11-01)

β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation leading to the development of glucocorticoid-induced osteonecrosis of the femoral head
by: Chenjie Xia, et al.
Published: (2024-02-01)

Cycloastragenol prevents bone loss via inhibiting osteoclast activity in glucocorticoid-induced osteonecrosis of the femoral head: An in vivo study
by: Gang Wang, et al.
Published: (2024-03-01)